Corticomedullary Mixed Tumor of the Adrenal Gland with Apparent F-18-Fluorodeoxyglucose Activity But No 68GA-DOTATATE Uptake on Positron Emission Tomography/Computed Tomography

Engur C. O., Apaydin T., ÖNEŞ T., Gozu H. I., ÖZGÜVEN S.

INDIAN JOURNAL OF NUCLEAR MEDICINE, vol.37, no.3, pp.297-298, 2022 (ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 37 Issue: 3
  • Publication Date: 2022
  • Doi Number: 10.4103/ijnm.ijnm_194_21
  • Journal Name: INDIAN JOURNAL OF NUCLEAR MEDICINE
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, EMBASE
  • Page Numbers: pp.297-298
  • Keywords: F-18-fluorodeoxyglucose positron emission tomography/computed tomography, Ga-68-DOTATATE positron emission tomography/computed tomography, adrenal gland, corticomedullary mixed tumor
  • Marmara University Affiliated: Yes

Abstract

Corticomedullary mixed tumor (CMT) is a single adrenal tumor mass composed histologically by an admixture of adrenal cortical and medullary cells. It is a rare condition, with approximately 20 cases reported to date. To our knowledge, the positron emission tomography (PET) imaging findings of this mostly benign tumor have not been reported in the literature. We present a case of CMT who was evaluated with both F-18-fluorodeoxyglucose (F-18-FDG) and Ga-68-DOTATATE. The hypermetabolic tumor seen on F-18-FDG PET/computed tomography scan showed no abnormal uptake by Ga-68-DOTATATE.